Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Intellia Therapeutics Inc | 12 | 0 | 0 | 0 | €23.40 | €60.13 | 156.944% |
| Insmed Inc. | 13 | 1 | 2 | 0 | €24.00 | €44.01 | 83.361% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.80 | €4.00 | 42.857% |
| Immunogen Inc. | 5 | 0 | 1 | 0 | €28.97 | - | - |
| ImmunityBio Inc. | 3 | 0 | 1 | 0 | €7.29 | €10.00 | 37.174% |
| Immunic Inc. | 6 | 3 | 0 | 2 | €1.14 | €5.48 | 382.978% |
| Icon plc | 18 | 0 | 3 | 0 | €291.40 | €319.67 | 9.701% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €18.40 | €45.10 | 145.082% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| Heron Therapeutics Inc. | 10 | 1 | 4 | 0 | €2.73 | €4.58 | 67.410% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €3.03 | - | - |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €39.08 | €50.33 | 28.794% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €41.60 | - | - |
| GSK plc | 1 | 0 | 0 | 0 | €20.81 | - | - |
| Grifols S.A. | 1 | 0 | 0 | 0 | €9.35 | - | - |
| Geron Corp. | 12 | 0 | 4 | 0 | €3.61 | €4.63 | 28.316% |
| Galmed Pharmaceuticals Ltd. | 7 | 0 | 3 | 0 | €0.40 | €63.93 | 16044.192% |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.56 | €10.56 | 131.760% |
| Fagron N.V. | 1 | 0 | 0 | 0 | €18.74 | €20.00 | 6.724% |
| Faes Farma S.A. | 1 | 0 | 0 | 0 | €3.48 | €6.00 | 72.414% |
| EyePoint Pharmaceuticals Inc. | 17 | 1 | 3 | 1 | €11.96 | €27.83 | 132.701% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €20.07 | €26.01 | 29.578% |
| Evolus Inc | 9 | 0 | 4 | 0 | €11.90 | €20.43 | 71.702% |
| Esperion Therapeutis.Inc. | 15 | 0 | 4 | 0 | €1.99 | €8.39 | 322.053% |